Corporate governance promotes transparency and accountability. The roles and responsibilities of the Company, its shareholders, the Board of directors and management are set out in law and in the corporate governance documents detailed on this page.
Corporate Governance Statement
Cochlear's Corporate Governance Statement summarises the Company's corporate governance practices and incorporates the disclosures required by the ASX Corporate Governance Council’s Corporate Governance Principles and Recommendations (4th Edition).
The Board is committed to applying the highest standards of corporate governance relevant to and appropriate for Cochlear's businesses. We continue to refine and improve the governance framework and practices in place to ensure they meet the standards expected by our shareholders.
Constitution and the Board
Cochlear is governed by a board of directors who, working with senior management, are responsible for overall business performance. Cochlear's Constitution defines the relationship between the Company, its shareholders, and the Board. The Board has adopted a charter to formalise and improve transparency regarding aspects of the functions and operations of the Board and its relationship with management.
Cochlear's business practices are governed by a series of codes and policies. It is the intention of Cochlear's board that these codes and policies are understood and strictly adhered to by all relevant parties and that they are reviewed and updated on a regular basis. These codes and policies include:
- Global Code of Conduct
- Whistleblower Protection Policy
- Continuous Disclosure Policy
- Trading Policy
- Risk Management Policy
- Shareholder Communications Policy
- Diversity & Inclusion Policy
- Share Ownership Policy
- Clawback Policy
- Environmental Policy
- Supplier Code of Conduct
Cochlear Whistleblower Service
Please report any suspected or actual misconduct in relation to Cochlear to the externally-operated Cochlear Whistleblower Service. This is a confidential service, available anywhere in the world, at any time, and you can elect to remain anonymous (subject to local laws and regulations).
- Audit and Risk Committee
- Medical Science Committee
- Nomination Committee
- People and Culture Committee
- Product and Services Innovation Committee
Workplace gender equality
In accordance with the requirements of the Workplace Gender Equality Act 2012 (Act), Cochlear lodges its annual public report with the Workplace Gender Equality Agency.
Declaration of conformity
Cochlear Nucleus Sound Processors
- Kanso® 2 Sound Processor
- Cochlear™ CP1150S Surgical Processor
- Nucleus® 7 Processing Unit
- Kanso™ Sound Processor
- Nucleus® CP920 Processing Unit
- Nucleus® CP910 Processing Unit
- Nucleus® CP810 Processing Unit
- Nucleus® CP802 Processing Unit
Cochlear Nucleus Remote Controllers
- Cochlear™ Remote Control
- Nucleus® CR230 Remote Assistant
- Nucleus® CR220 Intraoperative Remote Assistant
- Nucleus® CR210 Remote Control
- Nucleus® CR110 Remote Assistant
Cochlear Wireless Programming Pods
Baha® bone conduction implants
In accordance with requirements in the R&TTE Directive ( 1999/5/ EC ) you can find Declaration of Conformity for the Cochlear™ Baha® 4 Sound Processor, Baha® 5 Sound Processor, Baha® 5 SuperPower Sound Processor and the Cochlear™ True Wireless™ range here.